Similar articles

• The effect of diphenylhydantoin on sodium, potassium, magnesium-activated adenosine triphosphatase in microsomal fractions of rat and guinea pig brain and on whole homogenates of human brain.

  Rawson MD, Pincus JH. Rawson MD, et al. Biochem Pharmacol. 1968 Apr;17(4):573-9. doi: 10.1016/0006-2952(68)90273-6. Biochem Pharmacol. 1968. PMID: 4231236 No abstract available.
• Myocardial Na-K adenosine triphosphatase activity during reversal of ouabain toxicity with diphenylhydantoin.

  Spain RC, Chidsey CA. Spain RC, et al. J Pharmacol Exp Ther. 1971 Dec;179(3):594-8. J Pharmacol Exp Ther. 1971. PMID: 4257806 No abstract available.
• Mechanism of inhibition of catecholamine release from adrenal medulla by diphenylhydantoin and by low concentration of ouabain (10(-10) M).

  Gutman Y, Boonyaviroj P. Gutman Y, et al. Naunyn Schmiedebergs Arch Pharmacol. 1977 Feb;296(3):293-6. doi: 10.1007/BF00498696. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 138799
• A myocardial sarcolemma preparation and the ouabain-sensitive (Na plus-K plus)-ATPase.

  Stam AC Jr, Shelburne JW, Feldman D, Sonnenblick EH. Stam AC Jr, et al. Biochim Biophys Acta. 1969 Oct 21;189(2):304-7. doi: 10.1016/0005-2728(69)90058-9. Biochim Biophys Acta. 1969. PMID: 4311770 No abstract available.
• [Interaction of Na+, K+-ATPase with oubain].

  Nazarenko VI. Nazarenko VI. Ukr Biokhim Zh. 1974 Jul-Aug;46(4):531-43. Ukr Biokhim Zh. 1974. PMID: 4281547 Review. Russian. No abstract available.